FDA
-
-
-
-
-
-
-
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
-
-
-
-
-
-
-
CVRx nominates Michael Dale for board election
-
-
-
-
-
-
-
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
-
-
-
-
-
-
-
CVRx Reports Third Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
CVRx Announces Positive News on Outpatient Payment for Barostim
-
-
-
-
-
-
-
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
-
-
-
-
-
-
-
CVRx Reports Third Quarter 2024 Financial and Operating Results
-
327,801 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

